izpis_h1_title_alt

Ara h 2-specific IgE epitope-like peptides inhibit the binding of IgE to Ara h 2 and suppress lgE-dependent effector cell activation
ID Korošec, Peter (Author), ID Koren, Ana (Author), ID Debeljak, Jerneja (Author), ID Zahirović, Abida (Author), ID Skerbinjek-Kavalar, Maja (Author), ID Berce, Vojko (Author), ID Dejanović, Luka (Author), ID Luzar, Jernej (Author), ID Štrukelj, Borut (Author), ID Lunder, Mojca (Author)

.pdfPDF - Presentation file, Download (8,31 MB)
MD5: 3F2EEA4596BD6AF30245EB392A4B29B7
URLURL - Source URL, Visit https://onlinelibrary.wiley.com/doi/10.1111/cea.14314 This link opens in a new window

Abstract
Background: Clinical and experimental analyses indicate a pathognomonic role for allergen IgE crosslinking through epitope–paratope interactions as a major initial step in the cascade leading to effector cell activation and clinical manifestations of lgE-mediated food allergies. We aimed to undertake the initial development and assessment of Ara h 2-specific IgE epitope-like peptides that can bind to allergenspecific IgE paratopes and suppress effector cell activation. Methods: We performed biopanning, screening, IgE binding, selection and mapping of peptides. We generated synthetic peptides for use in all functional experiments. ImmunoCAP inhibition, basophil and mast cell activation tests, with LAD2 cells, a human mast cell line were performed. Twenty-six children or young adults who had peanut allergy were studied. Results: We identified and selected three linear peptides (DHPRFNRDNDVA, DHPRYGP and DHPRFST), and immunoblot analyses revealed binding to lgE from peanut-allergic individuals. The peptide sequences were aligned to the disordered region corresponding to the loop between helices 2 and 3 of Ara h 2, and conformational mapping showed that the peptides match the surface of Ara h 2 and h 6 but not other peanut allergens. In ImmunoCAP inhibition experiments, the peptides significantly inhibit the binding of IgE to Ara h 2 (p < .001). In basophil and mast cell activation tests, the peptides significantly suppressed Ara h 2-induced effector cell activation (p < .05) and increased the half-maximal Ara h 2 effective concentration (p < .05). Binding of the peptides to specific IgEs did not induce activation of basophils or mast cells. Conclusions: These studies show that the indicated peptides reduce the allergenic activity of Ara h 2 and suppress lgE-dependent basophil and mast cell activation. These observations may suggest a novel therapeutic strategy for food allergy based on epitope–paratop blocking.

Language:English
Keywords:Ara h 2, ImmunoCAP inhibition, basophil activation test, epitopes, mast cell activation test, paratopes, peanut allergy, peptides, specific IgE
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:Str. 636-647
Numbering:Vol. 53, iss. 6
PID:20.500.12556/RUL-147382 This link opens in a new window
UDC:616-056.43
ISSN on article:1365-2222
DOI:10.1111/cea.14314 This link opens in a new window
COBISS.SI-ID:151992835 This link opens in a new window
Publication date in RUL:03.07.2023
Views:1294
Downloads:72
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Clinical & experimental allergy
Shortened title:Clin. exp. allergy
Publisher:Wiley
ISSN:1365-2222
COBISS.SI-ID:515014681 This link opens in a new window

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.

Secondary language

Language:Slovenian
Keywords:alergeni, Ara h 2, test aktivacije bazofilcev, epitopi, inhibicija ImmunoCAP, test aktivacije mastocitov, paratopi, alergija na arašide, peptidi, specifični IgE

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P3-0360
Name:Celostna obravnava alergijskih bolezni in astme v Sloveniji: od epidemiologije do genetike

Funder:ARRS - Slovenian Research Agency
Project number:P4-0127
Name:Farmacevtska biotehnologija: znanost za zdravje

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back